0

CADUET از شرکت PHARMACIA

تصویر پیدا نشد !

اطلاعات داروی نمایش داده شده مستقیما از دیتابیس اطلاعات دارویی سازمان غذا و دارو آمریکا (FDA) استخراج می شود و مرتبا به روز رسانی می شود
داروی نمایش داده شده مورد تایید FDA می باشد و اطلاعات ثبت آن در زیر قابل مشاهده است

CADUET از شرکت PHARMACIA

New Drug Application (NDA): 021540

Company: PHARMACIA


Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
CADUET AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM EQ 5MG BASE;EQ 10MG BASE TABLET;ORAL Prescription

AB

 Yes No
CADUET AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM EQ 5MG BASE;EQ 20MG BASE TABLET;ORAL Prescription

AB

 Yes No
CADUET AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM EQ 5MG BASE;EQ 40MG BASE TABLET;ORAL Prescription

AB

 Yes No
CADUET AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM EQ 5MG BASE;EQ 80MG BASE TABLET;ORAL Prescription

AB

 Yes No
CADUET AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM EQ 10MG BASE;EQ 10MG BASE TABLET;ORAL Prescription

AB

 Yes No
CADUET AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM EQ 10MG BASE;EQ 20MG BASE TABLET;ORAL Prescription

AB

 Yes No
CADUET AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM EQ 10MG BASE;EQ 40MG BASE TABLET;ORAL Prescription

AB

 Yes No
CADUET AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM EQ 10MG BASE;EQ 80MG BASE TABLET;ORAL Prescription

AB

 Yes Yes
CADUET AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM EQ 2.5MG BASE;EQ 10MG BASE TABLET;ORAL Prescription

AB

 Yes No
CADUET AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM EQ 2.5MG BASE;EQ 20MG BASE TABLET;ORAL Prescription

AB

 Yes No
CADUET AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM EQ 2.5MG BASE;EQ 40MG BASE TABLET;ORAL Prescription

AB

 Yes No


Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
01/30/2004 ORIG-1 Approval

Type 4 – New Combination

STANDARD

Label (PDF)

Letter (PDF)

Review

https://www.accessdata.fda.gov/drugsatfda_docs/label/2004/21540_caduet_lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2004/21540ltr.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2004/021540S000_Caduet.cfm

Supplements
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels, Patient Package Insert Note Url
09/25/2020 SUPPL-48 Labeling-Package Insert

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021540s048lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/021540Orig1s048ltr.pdf
12/15/2020 SUPPL-47 Labeling-Package Insert

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021540Orig1s047lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/021540Orig1s047ltr.pdf
01/07/2021 SUPPL-46 Labeling-Package Insert

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021540s046lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/021540Orig1s046ltr.pdf
12/18/2019 SUPPL-45 Labeling-Package Insert

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021540s045lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/021540Orig1s045ltr.pdf
05/10/2019 SUPPL-44 Labeling-Package Insert

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020540s044lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/021540Orig1s044ltr.pdf
09/12/2018 SUPPL-43 Labeling-Package Insert

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021540s042s043lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2018/021540Orig1s042,021540Orig1s043REPLACEMENTltr.pdf
09/12/2018 SUPPL-42 Labeling-Package Insert

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021540s042s043lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2018/021540Orig1s042,021540Orig1s043REPLACEMENTltr.pdf
05/25/2018 SUPPL-41 Labeling-Package Insert

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021540s041lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2018/021540Orig1s041ltr.pdf
06/23/2017 SUPPL-39 Labeling-Package Insert

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021540s039lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/021540Origs039ltr.pdf
10/30/2017 SUPPL-38 Labeling-Package Insert

Label (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021540s038lbl.pdf
02/17/2015 SUPPL-37 Labeling-Package Insert

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021540s037lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/021540Orig1s037ltr.pdf
03/23/2015 SUPPL-36 Labeling-Package Insert

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021540s036lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/021540Orig1s036ltr.pdf
07/28/2014 SUPPL-35 Manufacturing (CMC)

Label is not available on this site.
05/22/2014 SUPPL-34 Labeling-Package Insert

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021540s034lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2014/021540Orig1s034ltr.pdf
04/21/2014 SUPPL-33 Manufacturing (CMC)

Label is not available on this site.
11/07/2013 SUPPL-31 Labeling-Package Insert

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021540s030s031lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/021540Orig1s030,s031ltr.pdf
11/07/2013 SUPPL-30 Labeling-Package Insert

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021540s030s031lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/021540Orig1s030,s031ltr.pdf
07/31/2013 SUPPL-29 Manufacturing (CMC)

Label is not available on this site.
10/31/2012 SUPPL-28 Labeling-Package Insert

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021540s028lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2012/021540Orig1s028ltr.pdf
07/26/2012 SUPPL-26 Labeling-Package Insert

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021540s023s026lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2012/021540Orig1s023,s026ltr.pdf
07/26/2012 SUPPL-23 Labeling-Package Insert

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021540s023s026lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2012/021540Orig1s023,s026ltr.pdf
02/17/2010 SUPPL-19 Labeling-Package Insert

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021540s019lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2010/021540s019ltr.pdf
07/20/2009 SUPPL-18 Labeling

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/021540s018lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2009/021540s018ltr.pdf
05/29/2008 SUPPL-14 Labeling

Letter (PDF)

Label is not available on this site.

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2008/021540s014ltr.pdf
09/20/2007 SUPPL-11 Labeling

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/021540s011lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2007/021540s011ltr.pdf
09/20/2007 SUPPL-9 Labeling

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/021540s009lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2007/021540s009ltr.pdf
04/13/2006 SUPPL-8 Labeling

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/021540s008lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2006/021540s008ltr.pdf
08/28/2006 SUPPL-6 Labeling

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/021540s006lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2006/021540s006ltr.pdf
09/27/2004 SUPPL-3 Labeling

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2004/21540s003lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2004/21540s003ltr.pdf


Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels,
Patient Package Insert		 Note Url
01/07/2021 SUPPL-46

Labeling-Package Insert

 Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021540s046lbl.pdf
12/15/2020 SUPPL-47

Labeling-Package Insert

 Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021540Orig1s047lbl.pdf
09/25/2020 SUPPL-48

Labeling-Package Insert

 Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021540s048lbl.pdf
12/18/2019 SUPPL-45

Labeling-Package Insert

 Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021540s045lbl.pdf
05/10/2019 SUPPL-44

Labeling-Package Insert

 Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020540s044lbl.pdf
09/12/2018 SUPPL-43

Labeling-Package Insert

 Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021540s042s043lbl.pdf
09/12/2018 SUPPL-42

Labeling-Package Insert

 Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021540s042s043lbl.pdf
05/25/2018 SUPPL-41

Labeling-Package Insert

 Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021540s041lbl.pdf
10/30/2017 SUPPL-38

Labeling-Package Insert

 Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021540s038lbl.pdf
06/23/2017 SUPPL-39

Labeling-Package Insert

 Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021540s039lbl.pdf
03/23/2015 SUPPL-36

Labeling-Package Insert

 Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021540s036lbl.pdf
02/17/2015 SUPPL-37

Labeling-Package Insert

 Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021540s037lbl.pdf
05/22/2014 SUPPL-34

Labeling-Package Insert

 Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021540s034lbl.pdf
11/07/2013 SUPPL-31

Labeling-Package Insert

 Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021540s030s031lbl.pdf
11/07/2013 SUPPL-30

Labeling-Package Insert

 Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021540s030s031lbl.pdf
10/31/2012 SUPPL-28

Labeling-Package Insert

 Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021540s028lbl.pdf
07/26/2012 SUPPL-26

Labeling-Package Insert

 Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021540s023s026lbl.pdf
07/26/2012 SUPPL-23

Labeling-Package Insert

 Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021540s023s026lbl.pdf
02/17/2010 SUPPL-19

Labeling-Package Insert

 Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021540s019lbl.pdf
07/20/2009 SUPPL-18

Labeling

 Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/021540s018lbl.pdf
09/20/2007 SUPPL-11

Labeling

 Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/021540s011lbl.pdf
09/20/2007 SUPPL-9

Labeling

 Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/021540s009lbl.pdf
08/28/2006 SUPPL-6

Labeling

 Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/021540s006lbl.pdf
04/13/2006 SUPPL-8

Labeling

 Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/021540s008lbl.pdf
09/27/2004 SUPPL-3

Labeling

 Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2004/21540s003lbl.pdf
01/30/2004 ORIG-1 Approval

 Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2004/21540_caduet_lbl.pdf


CADUET

TABLET;ORAL; EQ 5MG BASE;EQ 10MG BASE

TE Code = AB

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM EQ 5MG BASE;EQ 10MG BASE TABLET;ORAL Prescription No AB 205199 APOTEX
AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM EQ 5MG BASE;EQ 10MG BASE TABLET;ORAL Prescription No AB 203874 DR REDDYS
AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM EQ 5MG BASE;EQ 10MG BASE TABLET;ORAL Prescription No AB 200465 MYLAN
AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM EQ 5MG BASE;EQ 10MG BASE TABLET;ORAL Prescription No AB 207762 ZYDUS PHARMS
CADUET AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM EQ 5MG BASE;EQ 10MG BASE TABLET;ORAL Prescription Yes AB 021540 PHARMACIA

TABLET;ORAL; EQ 5MG BASE;EQ 20MG BASE

TE Code = AB

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM EQ 5MG BASE;EQ 20MG BASE TABLET;ORAL Prescription No AB 205199 APOTEX
AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM EQ 5MG BASE;EQ 20MG BASE TABLET;ORAL Prescription No AB 203874 DR REDDYS
AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM EQ 5MG BASE;EQ 20MG BASE TABLET;ORAL Prescription No AB 200465 MYLAN
AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM EQ 5MG BASE;EQ 20MG BASE TABLET;ORAL Prescription No AB 207762 ZYDUS PHARMS
CADUET AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM EQ 5MG BASE;EQ 20MG BASE TABLET;ORAL Prescription Yes AB 021540 PHARMACIA

TABLET;ORAL; EQ 5MG BASE;EQ 40MG BASE

TE Code = AB

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM EQ 5MG BASE;EQ 40MG BASE TABLET;ORAL Prescription No AB 205199 APOTEX
AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM EQ 5MG BASE;EQ 40MG BASE TABLET;ORAL Prescription No AB 203874 DR REDDYS
AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM EQ 5MG BASE;EQ 40MG BASE TABLET;ORAL Prescription No AB 200465 MYLAN
AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM EQ 5MG BASE;EQ 40MG BASE TABLET;ORAL Prescription No AB 207762 ZYDUS PHARMS
CADUET AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM EQ 5MG BASE;EQ 40MG BASE TABLET;ORAL Prescription Yes AB 021540 PHARMACIA

TABLET;ORAL; EQ 5MG BASE;EQ 80MG BASE

TE Code = AB

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM EQ 5MG BASE;EQ 80MG BASE TABLET;ORAL Prescription No AB 205199 APOTEX
AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM EQ 5MG BASE;EQ 80MG BASE TABLET;ORAL Prescription No AB 203874 DR REDDYS
AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM EQ 5MG BASE;EQ 80MG BASE TABLET;ORAL Prescription No AB 200465 MYLAN
AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM EQ 5MG BASE;EQ 80MG BASE TABLET;ORAL Prescription No AB 207762 ZYDUS PHARMS
CADUET AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM EQ 5MG BASE;EQ 80MG BASE TABLET;ORAL Prescription Yes AB 021540 PHARMACIA

TABLET;ORAL; EQ 10MG BASE;EQ 10MG BASE

TE Code = AB

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM EQ 10MG BASE;EQ 10MG BASE TABLET;ORAL Prescription No AB 205199 APOTEX
AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM EQ 10MG BASE;EQ 10MG BASE TABLET;ORAL Prescription No AB 203874 DR REDDYS
AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM EQ 10MG BASE;EQ 10MG BASE TABLET;ORAL Prescription No AB 200465 MYLAN
AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM EQ 10MG BASE;EQ 10MG BASE TABLET;ORAL Prescription No AB 207762 ZYDUS PHARMS
CADUET AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM EQ 10MG BASE;EQ 10MG BASE TABLET;ORAL Prescription Yes AB 021540 PHARMACIA

TABLET;ORAL; EQ 10MG BASE;EQ 20MG BASE

TE Code = AB

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM EQ 10MG BASE;EQ 20MG BASE TABLET;ORAL Prescription No AB 205199 APOTEX
AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM EQ 10MG BASE;EQ 20MG BASE TABLET;ORAL Prescription No AB 203874 DR REDDYS
AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM EQ 10MG BASE;EQ 20MG BASE TABLET;ORAL Prescription No AB 200465 MYLAN
AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM EQ 10MG BASE;EQ 20MG BASE TABLET;ORAL Prescription No AB 207762 ZYDUS PHARMS
CADUET AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM EQ 10MG BASE;EQ 20MG BASE TABLET;ORAL Prescription Yes AB 021540 PHARMACIA

TABLET;ORAL; EQ 10MG BASE;EQ 40MG BASE

TE Code = AB

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM EQ 10MG BASE;EQ 40MG BASE TABLET;ORAL Prescription No AB 205199 APOTEX
AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM EQ 10MG BASE;EQ 40MG BASE TABLET;ORAL Prescription No AB 203874 DR REDDYS
AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM EQ 10MG BASE;EQ 40MG BASE TABLET;ORAL Prescription No AB 200465 MYLAN
AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM EQ 10MG BASE;EQ 40MG BASE TABLET;ORAL Prescription No AB 207762 ZYDUS PHARMS
CADUET AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM EQ 10MG BASE;EQ 40MG BASE TABLET;ORAL Prescription Yes AB 021540 PHARMACIA

TABLET;ORAL; EQ 10MG BASE;EQ 80MG BASE

TE Code = AB

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM EQ 10MG BASE;EQ 80MG BASE TABLET;ORAL Prescription No AB 205199 APOTEX
AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM EQ 10MG BASE;EQ 80MG BASE TABLET;ORAL Prescription No AB 203874 DR REDDYS
AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM EQ 10MG BASE;EQ 80MG BASE TABLET;ORAL Prescription No AB 200465 MYLAN
AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM EQ 10MG BASE;EQ 80MG BASE TABLET;ORAL Prescription No AB 207762 ZYDUS PHARMS
CADUET AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM EQ 10MG BASE;EQ 80MG BASE TABLET;ORAL Prescription Yes AB 021540 PHARMACIA

TABLET;ORAL; EQ 2.5MG BASE;EQ 10MG BASE

TE Code = AB

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM EQ 2.5MG BASE;EQ 10MG BASE TABLET;ORAL Prescription No AB 203874 DR REDDYS
AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM EQ 2.5MG BASE;EQ 10MG BASE TABLET;ORAL Prescription No AB 207762 ZYDUS PHARMS
CADUET AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM EQ 2.5MG BASE;EQ 10MG BASE TABLET;ORAL Prescription Yes AB 021540 PHARMACIA

TABLET;ORAL; EQ 2.5MG BASE;EQ 20MG BASE

TE Code = AB

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM EQ 2.5MG BASE;EQ 20MG BASE TABLET;ORAL Prescription No AB 203874 DR REDDYS
AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM EQ 2.5MG BASE;EQ 20MG BASE TABLET;ORAL Prescription No AB 207762 ZYDUS PHARMS
CADUET AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM EQ 2.5MG BASE;EQ 20MG BASE TABLET;ORAL Prescription Yes AB 021540 PHARMACIA

TABLET;ORAL; EQ 2.5MG BASE;EQ 40MG BASE

TE Code = AB

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM EQ 2.5MG BASE;EQ 40MG BASE TABLET;ORAL Prescription No AB 203874 DR REDDYS
AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM EQ 2.5MG BASE;EQ 40MG BASE TABLET;ORAL Prescription No AB 207762 ZYDUS PHARMS
CADUET AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM EQ 2.5MG BASE;EQ 40MG BASE TABLET;ORAL Prescription Yes AB 021540 PHARMACIA
برچسب‌ها:

صفحات پیشنهادی

کلینیک ترک اعتیاد تهران

دکتر مهدی قاضی

متخصص اورولوژی مشهد

دکتر پروستات در مشهد

دکتر زگیل تناسلی در مشهد

وازکتومی در مشهد

مشاهده بیشتر

نظرات کاربران

مشاهده بیشتر

بیماری های روان پزشکی
بیماری های قلب و عروق
زیبایی و سلامت
مطالب آموزشی